PATENT CLAIM ANALYSIS

Application Number: 15922010
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-10
Patent Classification: ["514", "279000"]

Abstract:
The application describes treatment of hepatic encephalopathy using gastrointestinal specific antibiotics. One example of a gastrointestinal specific antibiotic is rifaximin.

Claim (Index 99):
The method of  claim 97 , wherein a breakthrough overt HE episode for subjects having a Conn score of 0 comprises a Conn and Asterixis score increase of 1 grade.

Metadata:
- Claim Count in Document: 48.0
- Percentile: 90.0
- Lexical Diversity: 1.22222
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['13768617', '15460704', '15824209', '14612697', '13737535']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8447836605580109
- 35 USC 102 Novelty (BERT): 0.568175887625649
- Combined Prediction Score: 0.8171228832647748
- Mean Citation Score: 500.831352
- Max Citation Score: 512.1798
- Similarity Product: 332.5129073887109

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test